Australia
Australia as a Strategic Gateway: The Economic and Regulatory Advantages of Clinical Manufacturing Down Under
Mark W. Womack; Jan Bekker; Melissa El Khouri
BioCina
PAO-07-25-CL-01Jul 14, 2025
Biotherapeutics
Building on Australia's Existing Biopharma Infrastructure
BioCina
PAO-11-24-RTM-07Nov 15, 2024
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Pharma's Almanac
PAO-03-24-CL-03Mar 08, 2024
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Pharma's Almanac
PAO-03-24-CL-02Mar 08, 2024
Roundtable
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
Pharma's Almanac
PAO-12-23-RT-01Dec 14, 2023